Patents expiring in 2035

US 9216198

Compositions and medical devices for controlled release of nitric oxide and methods of production thereof

The Board of Regents of the University of Texas System · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9216214

Replication-competent adenoviral vectors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

ZA 201308176

THERAPEUTIC TREATMENT

ASTRAZENECA AB [SE] · Granted Wed Dec 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Dec 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2015366947

A Method of Purifying Therapeutic Proteins

CSL LTD [AU] · Granted Thu Dec 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9221836

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9221763

Process for preparing biphenyl imidazole compounds

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9220737

Plant cell culture expressing human lysosomal proteins and uses thereof

Protalix Ltd. · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9220730

Methods of treating ischemic spasticity

The Regents of the University of California · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9220729

Ameliorating nervous systems disorders

The Regents of the University of California · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9220722

Microrna (miRNA) and downstream targets for diagnostic and therapeutic purposes

Julius-Maximilians-Universitat Wurzburg · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9220692

Methods of reducing symptoms in subjects using single dosage forms with tapering release rates

TEVA WOMEN'S HEALTH, INC. · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9220685

Hollow silica nanospheres and methods of making same

The Regents of the University of California · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9220683

Lipids and compositions for the delivery of therapeutics

Tekmira Pharmaceuticals Corporation · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9220676

Injectable in-situ crosslinked hydrogel and methods of making and using thereof

BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9220261

Volatile blends and the effects thereof on the navel orangeworm moth

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9221792

N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators

Agios Pharmaceuticals, Inc. · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9221838

Inhibitors of AKT activity

ALMAC DISCOVERY LIMITED · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9221843

Heteroaryl inhibitors of PDE4

Tetra Discovery Partners · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9222086

Compositions and methods for silencing genes expressed in cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9222091

Therapeutic compositions

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9222142

Adenoviruses and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9221878

Cyclosporin analogues for preventing or treating hepatitis C infection

Enanta Pharmaceuticals, Inc. · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9221772

Synthesis of syrbactin proteasome inhibitors

The Regents of the University of California · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9221858

Sialic acid analogs

Ultragenyx Pharmaceutical Inc. · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9220748

Macrocyclic proline derived HCV serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9220735

Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders

AKER BIOMARINE ANTARCTIC AS · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9220733

Solubilization of antigen components for removal from tissues

The Regents of the University of California · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9220706

Inhibition of leukemic stem cells by PP2A activating agents

THE UNITED STATES OF AMERICA NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR) · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9221800

Isoxazole treatments for diabetes

The Board of Regents of the University of Texas System · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9221840

Treating protein folding disorders with small molecule CFTR correctors

DISCOVERYBIOMED, INC. · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9220772

Anti-tumor antigen antibodies and methods of use

The Regents of the University of California · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2958945

KOMBINATIONSTHERAPIE MIT ANTIKÖRPERN GEGEN CLAUDIN 18.2 ZUR BEHANDLUNG VON KREBS

GANYMED PHARMACEUTICALS AG [DE] · Granted Wed Dec 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Dec 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9228188

Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression

Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9226919

Methods for dosing an orally active 1,2,4-oxadiazole

PTC THERAPEUTICS, INC. · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9228172

Inducible regulatory T-cell generation for hematopoietic transplants

Regents of the University of Minnesota · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9228014

Antibodies capable of blocking the interaction between CD48 and a CD48 receptor

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9226970

Oligomer modified diaromatic substituted compounds

Nektar Therapeutics · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9226910

Treatment for obesity

Jazz Pharmaceuticals International III Limited · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9226896

Crystalline freebase forms of a biphenyl compound

Theravance Biopharma R&D IP, LLC · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9227918

Short acting phenylalkylamine calcium channel blockers and uses thereof

Milestone Pharmaceuticals Inc. · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9226969

Salt form of a multi-arm polymer-drug conjugate

Nektar Therapeutics · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9226930

1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders

Addex Pharma, S.A. · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9226955

Allogeneic autophagosome-enriched composition for the treatment of disease

Providence Health & Services—Oregon · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9226921

Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9226881

Multi-functional composite powder

JGC Catalysts and Chemicals Ltd. · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9226937

Compositions containing resveratrol and nucleotides

RESVERATROL PARTNERS, LLC · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9228001

Mutants of cholesterol-dependent cytolysins and uses thereof

The Board of Regents of the University of Oklahoma · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9227044

Applicator for applying a fluid to a surface

AMNEAL PHARMACEUTICALS LLC · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)